RFK Jr. names 8 new members of CDC's vaccine advisory panel
Digest more
Kennedy said the picks will demand “definitive safety and efficacy data” for vaccine recommendations. His picks include at least two critics of mRNA coronavirus vaccines.
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
BioNTech is buying fellow German mRNA vaccine developer CureVac in all-stock transaction that values the acquired biotech at $1.25 billion.
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened vaccine standards for the virus.
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Trump administration vs. mRNA vaccines President Trump once heralded the speedy development of